Figure 4
Figure 4. Amino acid sequences of tryptic peptides of (A) amyloid fibril protein isolated from postmortem kidney of patient II-10, and (B) plasma κ light-chain from a member of the next generation (III-15) with biopsy-proven amyloidosis. The normal sequence of the constant region of κ light-chains is shown. Residue numbering is by Kabat et al.8 The lines indicate the sequences obtained by Edman degradation of HPLC-purified tryptic peptides. The parentheses at the ends of the amyloid fibril protein peptides (A) denote residues not completely verified because of decreasingly low Edman degradation yields. The X at residues 131 and 134 denote that no amino acid was identified at these positions. The dots at the ends of some plasma light-chain peptides (B) indicate that the peptide continued but was not analyzed further.

Amino acid sequences of tryptic peptides of (A) amyloid fibril protein isolated from postmortem kidney of patient II-10, and (B) plasma κ light-chain from a member of the next generation (III-15) with biopsy-proven amyloidosis. The normal sequence of the constant region of κ light-chains is shown. Residue numbering is by Kabat et al. The lines indicate the sequences obtained by Edman degradation of HPLC-purified tryptic peptides. The parentheses at the ends of the amyloid fibril protein peptides (A) denote residues not completely verified because of decreasingly low Edman degradation yields. The X at residues 131 and 134 denote that no amino acid was identified at these positions. The dots at the ends of some plasma light-chain peptides (B) indicate that the peptide continued but was not analyzed further.

Close Modal

or Create an Account

Close Modal
Close Modal